Premium
Mid‐trimester amniocentesis and antibiotic prophylaxis
Author(s) -
Gramellini Dandolo,
Fieni Stefania,
Casilla Giovanna,
Raboni Stefano,
Nardelli Giovanni Battista
Publication year - 2007
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.1809
Subject(s) - amniocentesis , medicine , abortion , obstetrics , gestation , antibiotic prophylaxis , pregnancy , amoxicillin , incidence (geometry) , odds ratio , antibiotics , retrospective cohort study , fetus , gynecology , prenatal diagnosis , surgery , genetics , physics , optics , microbiology and biotechnology , biology
Objectives and Methods Assuming that the rate of fetal loss after amniocentesis may be reduced in patients receiving antibiotic prophylaxis, we conducted a retrospective study on untreated versus treated patients receiving prophylactic antibiotics (amoxicillin/clavulanic‐acid or azithromycin) and evaluated the fetal loss rate within the 22nd week of gestation, also with respect to the risk of spontaneous abortion, both preexisting and related to mid‐trimester amniocentesis. Results Spontaneous abortion occurred in 22 cases out of 1744 (1.26%). The incidence of spontaneous abortion was 1.3% among patients treated with antibiotic prophylaxis and 1.2% among untreated patients. Between patients with risk factors that predated amniocentesis, the spontaneous fetal loss rate was 9.2% in untreated patients versus 2.3% in patients treated ( p = 0.10). In patients with procedure‐related risk factors at amniocentesis, the spontaneous abortion rate was, respectively, 2.2 and 1.2% ( p = 0.72). Conclusion Our data demonstrate that antibiotic prophylaxis does not reduce the risk of spontaneous abortion within the 22nd week of gestation. Compared with untreated patients, patients treated with amoxicillin showed the lower fetal loss rate (1.16 vs 0.31%), but the difference was not statistically significant (odds ratio ( OR ) = 3.68, p = 0.32). The same was true for patients with preexisting risks ( OR = 4.25, p = 0.10). Copyright © 2007 John Wiley & Sons, Ltd.